These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 796848)

  • 1. [Obtaining active BCG substrains resistant to HINA].
    Gel'berg SI; Pozniak SB
    Probl Tuberk; 1976 Sep; (9):64-9. PubMed ID: 796848
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs.
    Dworski M
    Am Rev Respir Dis; 1973 Aug; 108(2):294-300. PubMed ID: 4578541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of protective effect of killed and live BCG bacilli and INH-resistant tubercle bacilli in guinea pigs].
    Paklerska-Pobratyn H; Kostrzeński W
    Gruzlica; 1968 Jun; 36(6):509-16. PubMed ID: 4970098
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production and laboratory examination of INH-resistant BCG vaccine].
    Milinković M
    Plucne Bolesti Tuberk; 1971; 23(4):347-53. PubMed ID: 4948961
    [No Abstract]   [Full Text] [Related]  

  • 5. [Different pathogenic power of the original BCG strain of the Pasteur Institute and of an isoniazid resistant strain. Histopathological study and significance of local abscesses after inoculation of guinea pig].
    Levaditi JC; Baloquet G; Kosloff-Senechal ; Augier J; Augier S; Baret M
    Sem Hop; 1975 Apr; 51(17):1167-73. PubMed ID: 174202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. II. Field trial in man.
    Vandiviere HM; Dworski M; Melvin IG; Watson KA; Begley J
    Am Rev Respir Dis; 1973 Aug; 108(2):301-13. PubMed ID: 4578542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP
    Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various experimental diseases induced in guinea pigs by the historical Institut Pasteur BCG strain and by the B-1 positive catalase strain. Study of the viability of the inoculated bacteria].
    Levaditi JC; Kosloff-Sénéchal F; Balouet G; Augier J
    Ann Inst Pasteur (Paris); 1968 Dec; 115(6):1053-62. PubMed ID: 4890580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of various BCG substrains].
    Milinković M
    Tuberkuloza; 1968; 20(3):116-24. PubMed ID: 4987222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the development of drug-resistant tubercle bacilli in experimental animal tuberculosis].
    Yamanouchi T; Sawai A; Hori M
    Kekkaku; 1973 Jul; 48(7):277-95. PubMed ID: 4200057
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance in the Swedish/Norwegian BCG strain.
    Hesselberg I
    Bull World Health Organ; 1972; 46(4):503-7. PubMed ID: 4559464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 14. Five cases of child tuberculosis caused by strains primarily resitant to all three main anti-tuberculosis drugs.
    Brander E; Aho K; Wasz-Höckert O
    Scand J Respir Dis; 1967; 48(1):76-80. PubMed ID: 4964559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].
    Blanco Ramos JR; Rosel Rioja L; Dopereiro Gómez R; Oteo Revuelta JA
    An Med Interna; 1997 Aug; 14(8):433-4. PubMed ID: 9376493
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth of a drug-resistant strain of Mycobacterium bovis (BCG) in normal and immunized mice.
    Collins FM; Miller TE
    J Infect Dis; 1969 Nov; 120(5):517-33. PubMed ID: 4899610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pattern of a test with isoniazid-resistant BCG in a strongly tuberculinized environment].
    Baroni V; Giaconi G
    G Ital Mal Torace; 1969; ():Suppl 1:56-8. PubMed ID: 4893882
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antitubercular vaccination with isoniazid-resistant BCG in the town of Sondalo].
    Giaconi G; Parravicini C
    G Ital Mal Torace; 1966; 20(6):385-90. PubMed ID: 4872420
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of isoniazid on BCG-mediated tumor immunity.
    Romolo JL; Loyd B; Cohen MH
    Surg Forum; 1977; 28():158-9. PubMed ID: 364713
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.